VAZ-50004-55236
3 vaccinations
14 coded responses
37 check-ins
14 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 520 / IA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Survey response — day 0, dose 1MedDRA: Dysgeusia, Feeling hot, Paraesthesia oral — Feeling: GoodFree text: Tongue tingling and hot, metallic tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Paraesthesia oral — Feeling: Good · Site: Pain · Abdominal painFree text: Tongue tingling, mild dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-03-28
- 2021-03-29
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Good · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus, Vertigo — Feeling: Poor · Fatigue or tiredness, Nausea · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Vertigo, itchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-01
Survey response — day 7, dose 1MedDRA: Vertigo — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-08
-
2021-04-15
Dose 2 — Pfizer-BioNTech
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort, Dizziness, Dyspnoea — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Dizzy, heavy chest, short of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Wheezing — Feeling: Good · ChillsFree text: WheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-04-29
- 2021-05-06
-
2021-05-13
Survey response — day 28, dose 2MedDRA: Chills, Headache — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headaches and chillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-20
Survey response — day 35, dose 2MedDRA: Migraine — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
- 2021-06-09
-
2021-06-09
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-15
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-02
- 2021-10-03
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Abdominal pain · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-10-05
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-06
-
2021-10-06
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
-
2021-11-04
Survey response — day 35, dose 3MedDRA: Abdominal pain, Migraine — Feeling: PoorFree text: Abdominal pain and migraineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Survey response — day 42, dose 3MedDRA: Migraine — Feeling: FairFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Dysuria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Burning urinationMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-31
Survey response — 6 months, dose 3MedDRA: COVID-19, Cystitis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Several bladder infections CoVidMedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-04
-
2022-10-02
Survey response — 12 months, dose 3MedDRA: Chest pain, Hypoaesthesia, Rash, Vertigo — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Rash, vertigo, numbness, chest painMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-10-04
- 2022-10-04
- 2022-10-04
- 2022-10-04
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-31 | Unsuccessful | |
| 2021-04-01 | Unsuccessful | |
| 2021-05-13 | Unsuccessful | |
| 2021-05-20 | Successful 2021-06-09 |
Participant prefers to complete VAERS report online |
| 2021-10-05 | Successful 2021-10-06 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-12-30 | Successful 2022-01-04 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-03-31 | Unsuccessful | |
| 2022-10-02 | Unsuccessful |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Tongue tingling and hot, metallic taste
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Tongue tingling, mild dizziness
Systemic reaction (other): Dizziness
Systemic reaction (other): Vertigo, itching
Release 6 — day 7, dose 1
Systemic reaction (other): Vertigo
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Dizzy, heavy chest, short of breath
Systemic reaction (other): Wheezing
Release 8 — day 28, dose 2
Symptoms: Headaches and chills
Release 8 — day 35, dose 2
Symptoms: Migraine
Release 10 — day 35, dose 3
Symptoms: Abdominal pain and migraine
Release 10 — day 42, dose 3
Symptoms: Migraine
Release 10 — 3 months, dose 3
Symptoms: Burning urination
Release 11 — 6 months, dose 3
Symptoms: Several bladder infections CoVid
Release 12 — 12 months, dose 3
Symptoms: Rash, vertigo, numbness, chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Cystitis | · | · | ✓ |
| SD | Dysuria | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release